Skip to main content
Clinical Trials/NCT02468362
NCT02468362UnknownPhase 2

Long Term Outcomes After Laparoscopic Intersphincteric Resection With Total Mesorectal Excision for Low Rectal Cancer: a Double Blind Randomized Clinical Trial

Mansoura University0 sites112 target enrollmentStarted: April 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 2
Enrollment
112
Primary Endpoint
Disease Free survival

Study Overview

Brief Summary

Through a double blinded study, patients with low rectal cancer will be randomized into two equal groups to compare between the 5 year disease free survival as a primary outcome measure.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Low rectal cancer below 5 cm from the anal verge
  • •Fit for laparoscopic total mesorectal excsion
  • •T2, T3 rectal cancer
  • •No distant metstasis

Exclusion Criteria

  • •T1, AND T4
  • •Distant metastasis
  • •Tumor infiltrating the dentate line
  • •unwilling to participate

Arms & Interventions

Laparoscopic group

Active Comparator

Intervention: laparoscopic intersphincteric resection (Procedure)

Open group

Active Comparator

Intervention: open intersphincteric resection (Procedure)

Outcomes

Primary Outcomes

Disease Free survival

Time Frame: 5 years

Secondary Outcomes

  • Local recurrence(5 years)
  • 5 year survival(5 years)
  • Distant metstasis(5 years)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Osama Mohammad Ali ElDamshety

surgical oncology

Mansoura University

Similar Trials